Featured Research

from universities, journals, and other organizations

Methods to repair kidney cells, assess kidney function on the horizon

Date:
April 16, 2013
Source:
Medical College of Georgia at Georgia Regents University
Summary:
Researchers may have found a way to block kidney-destroying inflammation and help damaged kidney cells recover. In a related study, they report progress on a non-invasive method to assess how much kidney function has survived a serious bout of inflammation or a chronic problem like high blood pressure.

Drs. Michael P. Madaio (from left), Nino Kvirkvelia and Tracy L. McGaha may have found a way to block kidney-destroying inflammation and help damaged kidney cells recover. In a related study, they report progress on a non-invasive method to assess how much kidney function has survived a serious bout of inflammation or a chronic problem like high blood pressure.
Credit: Phil Jones, Georgia Regents University

Researchers may have found a way to block kidney-destroying inflammation and help damaged kidney cells recover.

Related Articles


In a related study, they report progress on a non-invasive method to assess how much kidney function has survived a serious bout of inflammation or a chronic problem like high blood pressure.

The diagnostic tool could help physicians make hard choices about whether a patient has enough kidney function left to benefit from treatment or whether dialysis or a transplant is in their future, said Dr. Michael P. Madaio, nephrologist and Chairman of the Department of Medicine at the Medical College of Georgia at Georgia Regents University.

If the kidneys can be saved, this approach could also aid optimal delivery of drugs directly to ailing kidney filters.

Significant infections, an oxygen-depriving critical illness or injury, diabetes and uncontrolled hypertension all can take a serious or deadly toll on the kidneys.

In an effort to better protect them, researchers induced acute kidney inflammation, or nephritis, in mice then gave them prostaglandin E2 . The kidneys' filtering units promptly recovered. "The cells got better, the kidneys got better," said Madaio, corresponding author of the study in the American Journal of Physiology-Renal Physiology.

While prostaglandins are better known as natural pro-inflammatory lipid compounds, prostaglandin E2 has an anti-inflammatory effect. The researchers suspected -- and found -- it also had the bonus regenerative properties.

"We've already got numerous ways to block inflammation, but what we hope is the magic here is the ability to also help injured kidney cells recover," Madaio said.

In the related study, they found what appears to be a good indicator of kidney function that could help physicians and patients optimize treatment. "It's hard to determine the extent of disease from the current ways we measure kidney function," Madaio said. If it seems like treatment should be tried regardless, current regimes such as immunosuppressive drugs that block inflammation, for example, have serious side effects, including leaving patients vulnerable for additional infections.

In the search for a better way, researchers put a fluorescent tag on a human monoclonal antibody for a collagen found only in the kidney, lungs, and ears; injected it in mice with active kidney disease; then looked for antibody-binding in the kidney, said Dr. Tracy L. McGaha, MCG immunologist and co-corresponding author of the study in Kidney International.

This collagen is part of the base structure of kidney filters and its triple-helix configuration means the collagen molecules must hook together to work. The antibody the researchers used recognizes the stalks where collagen molecules connect, so it only binds when that bond is broken, an early indicator of kidney damage and lost function.

"When you have inflammation in the kidneys, the ends break apart, expose that little domain and the antibody can recognize it," McGaha said. The tagging system worked in the mice as well as tissue taken from patients with various kidney diseases.

This affinity for kidney filters means the antibody also could be used to directly deliver therapy to the filters, enhancing efficacy while reducing side effects. Similar approaches already are being used in cancer, McGaha said. Prostaglandin E2 may one day be one of those targeted therapies, he and Madaio noted.

Unfortunately, there are typically no early signs of kidney injury. When physicians suspect it, they look in the blood for levels of substances such as creatinine, a byproduct of metabolism which kidneys normally eliminate, and/or look to see if the normally fist-sized organs have shrunk, a sign of scarring. By the time either occurs, serious kidney damage has been done, Madaio said. Kidney biopsies, which provide a limited sample size and have their own set of complications, provide limited information as well.

At least in this early stage, the tagged antibody seems to have the current methods beat. "Before you see increases in protein excretion in the urine, before you see changes in the blood chemistry, you see this exposure," McGaha said.

To translate to humans, the labeled antibodies likely would need to be paired with powerful imaging technology such as the PET scanner to enable a full assessment of both kidneys, McGaha said. Antibodies, which are part of the normal immune response, also will have to be engineered so they only bind to their target, and don't also drive more inflammation, which is their usual role.

Every day, the kidneys filter about a quarter of the blood in the body, deciding what to keep, such as nutrients, and what to flush, such as excess sodium or a toxin. This aggressive job makes the kidneys particularly vulnerable to changes in blood pressure, increased inflammation and or toxins circulating in the body.


Story Source:

The above story is based on materials provided by Medical College of Georgia at Georgia Regents University. Note: Materials may be edited for content and length.


Journal References:

  1. Kapil Chaudhary, Daniel T Kleven, Tracy L McGaha, Michael P Madaio. A human monoclonal antibody against the collagen type IV α3NC1 domain is a non-invasive optical biomarker for glomerular diseases. Kidney International, 2013; DOI: 10.1038/ki.2013.99
  2. N. Kvirkvelia, M. McMenamin, K. Chaudhary, M. Bartoli, M. P. Madaio. Prostaglandin E2 promotes cellular recovery from established nephrotoxic serum nephritis in mice, prosurvival, and regenerative effects on glomerular cells. AJP: Renal Physiology, 2013; 304 (5): F463 DOI: 10.1152/ajprenal.00575.2012

Cite This Page:

Medical College of Georgia at Georgia Regents University. "Methods to repair kidney cells, assess kidney function on the horizon." ScienceDaily. ScienceDaily, 16 April 2013. <www.sciencedaily.com/releases/2013/04/130416121748.htm>.
Medical College of Georgia at Georgia Regents University. (2013, April 16). Methods to repair kidney cells, assess kidney function on the horizon. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2013/04/130416121748.htm
Medical College of Georgia at Georgia Regents University. "Methods to repair kidney cells, assess kidney function on the horizon." ScienceDaily. www.sciencedaily.com/releases/2013/04/130416121748.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins